- Home
- ZNTL vs SRG Comparison
ZNTL vs SRG Comparison
Compare ZNTL & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.67
HOLD
Current Price
$2.70
Company Overview
Basic Information| Metric | ZNTL | SRG |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.7M | 166.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | SRG |
|---|---|---|
| Price | $2.67 | $2.70 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 557.3K | 183.8K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.87 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,425,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $2.43 |
| 52 Week High | $3.95 | $4.56 |
Technical Indicators
Market Signals| Indicator | ZNTL | SRG |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 34.63 |
| Support Level | $1.29 | $2.72 |
| Resistance Level | $2.69 | $2.97 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 32.46 | 14.81 |
Price Performance
Historical Comparison ZNTL
SRG
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.